Evidence map›Paper›PMID 36612204›Full record

ArticleCancers2022

CD3

Topias Karjula, Hanna Elomaa, Anne Niskakangas, Olli Mustonen, Iiris Puro, Teijo Kuopio, Maarit Ahtiainen, Jukka-Pekka Mecklin, Toni T Seppälä, Erkki-Ville Wirta and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Topias KarjulaSurgery Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014 Oulu, Finland.ORCID 0000-0002-2342-6034
Hanna ElomaaDepartment of Biological and Environmental Science, University of Jyväskylä, 40014 Jyväskylä, Finland.ORCID 0000-0002-5378-7703
Anne NiskakangasSurgery Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014 Oulu, Finland.
Olli MustonenSurgery Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014 Oulu, Finland.
Iiris PuroSurgery Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014 Oulu, Finland.
Teijo KuopioDepartment of Biological and Environmental Science, University of Jyväskylä, 40014 Jyväskylä, Finland.ORCID 0000-0003-3503-4094
Maarit AhtiainenDepartment of Pathology, Central Finland Health Care District, 40620 Jyväskylä, Finland.ORCID 0000-0002-3263-2307
Jukka-Pekka MecklinDepartment of Education and Research, Central Finland Health Care District, 40620 Jyväskylä, Finland.
Toni T SeppäläFaculty of Medicine and Health Technology, Tampere University and TAYS Cancer Center, Tampere University Hospital, 33520 Tampere, Finland.ORCID 0000-0002-4940-3498
Erkki-Ville WirtaFaculty of Medicine and Health Technology, Tampere University and TAYS Cancer Center, Tampere University Hospital, 33520 Tampere, Finland.ORCID 0000-0002-2255-6136
Eero SihvoCentral Hospital of Central Finland, 40014 Jyväskylä, Finland.
Juha P VäyrynenCancer and Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014 Oulu, Finland.ORCID 0000-0002-8683-2996
Fredrik YannopoulosSurgery Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014 Oulu, Finland.
Olli HelminenSurgery Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014 Oulu, Finland.
Oulu University Hospital · FICentral Finland Health Care District · FITampere University Hospital · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to evaluate the prognostic value of CD3

Indexed as

colorectal carcinomaprogrammed death 1programmed death ligand 1pulmonary metastasestumour-infiltrating lymphocytes

Identifiers

PMID36612204
PMCPMC9818882
OpenAlexW4313361511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.